Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study
Authors
Keywords
-
Journal
Clinical and Molecular Hepatology
Volume 27, Issue 1, Pages 144-156
Publisher
The Korean Association for the Study of the Liver
Online
2020-12-07
DOI
10.3350/cmh.2020.0095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression
- (2020) Junying Chen et al. Frontiers in Oncology
- Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
- (2019) Changhoon Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
- (2019) Jeong Il Yu et al. Cancer Medicine
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function
- (2018) Peter T. Sage et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
- (2018) Maarten Versteven et al. Frontiers in Immunology
- Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway
- (2018) Marco Durante et al. Frontiers in Oncology
- A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.
- (2018) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
- (2018) Yang Liu et al. Journal of Hematology & Oncology
- Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
- (2018) Gyu Sang Yoo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
- (2018) Chia-Jen Wu et al. OncoImmunology
- Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
- (2018) Sung-Won Shin et al. Marine Drugs
- Radiotherapy as a New Player in Immuno-Oncology
- (2018) Shang-Jui Wang et al. Cancers
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model
- (2017) Kyoung-Jin Kim et al. Oncotarget
- Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
- (2017) Yuki Muroyama et al. Cancer Immunology Research
- Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
- (2017) Jeong Il Yu et al. Scientific Reports
- Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma
- (2016) David Friedman et al. HEPATOLOGY RESEARCH
- Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
- (2016) Jeong Il Yu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
- (2016) Jian-Fei Tu et al. Scientific Reports
- Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells
- (2016) S. J. Dovedi et al. Cancer Immunology Research
- Current clinical trials testing the combination of immunotherapy with radiotherapy
- (2016) Josephine Kang et al. Journal for ImmunoTherapy of Cancer
- Abscopal effects of radiation therapy: A clinical review for the radiobiologist
- (2015) Shankar Siva et al. CANCER LETTERS
- The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
- (2015) Kobe Reynders et al. CANCER TREATMENT REVIEWS
- Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
- (2015) Andrew B Sharabi et al. LANCET ONCOLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2015) Kelly J. Lafaro et al. Surgical Oncology Clinics of North America
- DNA Comet Giemsa Staining for Conventional Bright-Field Microscopy
- (2014) Andreyan Osipov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Radiation Enhances Regulatory T Cell Representation
- (2010) Evelyn L. Kachikwu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started